Early-stage prostate cancer diagnostic test utilizing advanced glycan analysis for highly accurate detection. Designed to identify prostate cancer at initial stages, enabling timely clinical intervention and improved patient outcomes.
Manufactured by
Bratislava, Slovakia
At Glycanostics, our aim is to develop, clinically validate register an affordable, non-invasive next-gen liquid biopsy prostate cancer diagnostic test with accuracy of up to 90%.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biomerica, Inc.
United States · 2 relevant products
Rayto Life and Analytical Sciences Co., Ltd.
China · 1 relevant product
Operon S.A.
Spain · 1 relevant product
Berkeley Health Ltd
United Kingdom · 2 relevant products
Zybio Inc.
China · 1 relevant product
Singlera GENOMICS (SHANGHAI) Ltd.
China · 7 relevant products
Atlas Link, Inc.
United States · 1 relevant product
Zhejiang Orient Gene Biotech Co.,Ltd.
China · 1 relevant product
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
PRIMA Lab SA
Switzerland · 1 relevant product
73 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 107 closest product alternatives
Biomerica, Inc. · United States
An advanced diagnostic test for prostate cancer screening. Designed as an at-home screening product targeting high-prevalence cancer detection.
Rayto Life and Analytical Sciences Co., Ltd. · China
Immunoassay for PSA measurement in prostate cancer screening and monitoring. Supports clinical decision-making in urology.
Operon S.A. · Spain
A diagnostic test for the detection and measurement of Prostate Specific Antigen in human samples. Used for in vitro diagnosis and monitoring of prostate health.
Berkeley Health Ltd · United Kingdom
Rapid self-test kit for prostate PSA screening enabling home-based detection and early identification of prostate health concerns. The test delivers accurate results comparable to clinical laboratory analysis with simple instructions and quick turnaround. ISO 13485:2016 certified in-vitro diagnostic device designed for patient convenience and accessibility.
Zybio Inc. · China
Immunoassay for prostate-specific antigen measurement in prostate cancer screening. Provides quantitative measurement for clinical decision-making.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A specialized molecular diagnostic test for early detection and risk assessment of pancreatic cancer using DNA methylation technology. Supports early diagnosis of this highly aggressive malignancy.
Atlas Link, Inc. · United States
A tumor marker test for detecting prostate specific antigen in qualitative and semi-quantitative formats. This test is used for prostate cancer screening and monitoring.
Berkeley Health Ltd · United Kingdom
Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.
Zhejiang Orient Gene Biotech Co.,Ltd. · China
Diagnostic test for measurement of prostate-specific antigen in serum. Supports screening for prostate cancer and monitoring of prostate health.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
PRIMA Lab SA · Switzerland
Self-test for the detection of the Prostate-Specific Antigen (PSA) in whole blood samples
95 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products